Tag: CBT > Cannabis DEA

Cannabis Rescheduling

House GOP Moves Forward on Blocking Trump Administration’s Power to Reschedule Cannabis

The House Appropriations Committee advanced a funding bill that prevents the Department of Justice from using funds to reclassify the plant.

September 11, 2025

Cannabis Rescheduling

Trump’s Forthcoming Rescheduling Decision, Congressman’s Marijuana 1-to-3 Act Lead CBT’s Top Stories in August

President Donald Trump said his decision on whether to change cannabis’s control status will come in the ‘next few weeks.’

August 28, 2025

Top Stories

ICE Raids, Texas Hemp THC Ban, Federal Bills Lead CBT Top Stories in July

The raids at Glass House and Texas’ pursuit to prohibit intoxicating hemp products remain ongoing storylines, as US lawmakers try to block rescheduling.

July 31, 2025

Cannabis Rescheduling

Trump’s New DEA Administrator Omits Cannabis Rescheduling From Top Priorities

Terrance Cole did not include rescheduling among his eight strategic priorities upon being sworn in, a U-turn from his confirmation hearing.

July 28, 2025

Cannabis Rescheduling

Cannabis Industry Stakeholders React to DEA Head Terrance Cole’s Confirmation

Proponents of cannabis rescheduling, and more broadly descheduling, are hoping Cole ‘listens to the experts’ and ‘follows the science.’

July 22, 2025

Cannabis Rescheduling

UPDATE: US Senate Confirms Trump’s DEA Administrator Pick

After the Senate invoked cloture, Terrance Cole was confirmed as the Drug Enforcement Administration’s next leader.

July 18, 2025

Cannabis Rescheduling

US House Subcommittee Advances Bill to Prevent Cannabis Rescheduling Under DOJ

The House appropriations bill would block the Department of Justice from using funds to reschedule or deschedule cannabis.

July 16, 2025

Cannabis Rescheduling

DEA Provides No Cannabis Rescheduling Update After 180 Days

The Drug Enforcement Administration still has yet to fix a briefing schedule for an interlocutory appeal as Trump’s nominee awaits Senate confirmation.

July 8, 2025

Industry Headlines

MMJ to File Emergency Injunction Against DEA’s ‘Unconstitutional Marijuana Hearing’

MMJ BioPharma Cultivation, a company seeking DEA registration to cultivate cannabis for research, is hoping to avoid an administrative hearing.

May 1, 2025

Cannabis Rescheduling

Doctors Group Left Out of DEA’s Cannabis Rescheduling Hearing Drops Lawsuit

Doctors for Drug Policy Reform preserves the right to refile the case should the Drug Enforcement Administration opt to keep cannabis a Schedule I drug.

April 21, 2025

Cannabis Rescheduling

DEA Judge’s Orders, Trump’s DEA Pick, Doctors’ Rescheduling Appeal Lead CBT’s Top Stories in February

The administrative law judge’s orders regarding a trio of pro-rescheduling participants led Cannabis Business Times’ most-read articles this month.

February 26, 2025

Legislation and Regulation

DOJ Will No Longer Defend Administrative Law Judges From Removal

The announcement could bolster MMJ International Holdings’ ongoing lawsuit against the DEA over a medical cannabis research application.

February 25, 2025